Terms: = Endocrine gland cancer AND NRG1, ENSG00000157168, 3084, SMDF, NDF, HRGA, HRG1, HGL, GGF2, GGF, ARIA AND Diagnosis
14 results:
1. Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden.
Zheng G; Faber MT; Wang J; Baandrup L; Hertzum-Larsen R; Sundström K; Kjær SK
Br J Cancer; 2024 May; 130(8):1279-1285. PubMed ID: 38347096
[TBL] [Abstract] [Full Text] [Related]
2. PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma.
Chapin WJ; Reiss KA
Hematol Oncol Clin North Am; 2022 Oct; 36(5):1019-1032. PubMed ID: 36154785
[TBL] [Abstract] [Full Text] [Related]
3. Glycemic Changes and Weight Loss Precede Pancreatic Ductal Adenocarcinoma by up to 3 Years in a Diverse Population.
Brewer MJ; Doucette JT; Bar-Mashiah A; Glickman JW; Kessel E; Aronson A; Lucas AL
Clin Gastroenterol Hepatol; 2022 May; 20(5):1105-1111.e2. PubMed ID: 34358720
[TBL] [Abstract] [Full Text] [Related]
4. Early-Onset Pancreas cancer: Clinical Descriptors, Genomics, and Outcomes.
Varghese AM; Singh I; Singh R; Kunte S; Chou JF; Capanu M; Wong W; Lowery MA; Stadler ZK; Salo-Mullen E; Saadat LV; Wei AC; Reyngold M; Basturk O; Benayed R; Mandelker D; Iacobuzio-Donahue CA; Kelsen DP; Park W; Yu KH; O'Reilly EM
J Natl Cancer Inst; 2021 Sep; 113(9):1194-1202. PubMed ID: 33755158
[TBL] [Abstract] [Full Text] [Related]
5. Antihistamine use and risk of ovarian cancer: A population-based case-control study.
Verdoodt F; Pottegård A; Dehlendorff C; Jäättelä M; Hallas J; Friis S; Kjaer SK
Maturitas; 2019 Feb; 120():47-52. PubMed ID: 30583764
[TBL] [Abstract] [Full Text] [Related]
6. Statin use and mortality among ovarian cancer patients: A population-based cohort study.
Verdoodt F; Kjaer Hansen M; Kjaer SK; Pottegård A; Friis S; Dehlendorff C
Int J Cancer; 2017 Jul; 141(2):279-286. PubMed ID: 28411390
[TBL] [Abstract] [Full Text] [Related]
7. Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.
Jendrzejewski J; Liyanarachchi S; Nagy R; Senter L; Wakely PE; Thomas A; Nabhan F; He H; Li W; Sworczak K; Ringel MD; Kirschner LS; de la Chapelle A
Thyroid; 2016 Sep; 26(9):1276-84. PubMed ID: 27342578
[TBL] [Abstract] [Full Text] [Related]
8. Low-dose aspirin use and the risk of ovarian cancer in Denmark.
Baandrup L; Kjaer SK; Olsen JH; Dehlendorff C; Friis S
Ann Oncol; 2015 Apr; 26(4):787-792. PubMed ID: 25538177
[TBL] [Abstract] [Full Text] [Related]
9. BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.
Paul BT; Blanchard Z; Ridgway M; ElShamy WM
Oncogene; 2015 Jun; 34(23):3036-52. PubMed ID: 25132263
[TBL] [Abstract] [Full Text] [Related]
10. Identifying patients with undetected pancreatic cancer in primary care: an independent and external validation of Qcancer(®) (Pancreas).
Collins GS; Altman DG
Br J Gen Pract; 2013 Sep; 63(614):e636-42. PubMed ID: 23998844
[TBL] [Abstract] [Full Text] [Related]
11. Identifying women with undetected ovarian cancer: independent and external validation of Qcancer(®) (Ovarian) prediction model.
Collins GS; Altman DG
Eur J Cancer Care (Engl); 2013 Jul; 22(4):423-9. PubMed ID: 23121234
[TBL] [Abstract] [Full Text] [Related]
12. Identifying patients with suspected pancreatic cancer in primary care: derivation and validation of an algorithm.
Hippisley-Cox J; Coupland C
Br J Gen Pract; 2012 Jan; 62(594):e38-45. PubMed ID: 22520674
[TBL] [Abstract] [Full Text] [Related]
13. Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm.
Hippisley-Cox J; Coupland C
BMJ; 2011 Jan; 344():d8009. PubMed ID: 22217630
[TBL] [Abstract] [Full Text] [Related]
14. Mesodermal (müllerian) adenosarcoma of the ovary: a clinicopathologic analysis of 40 cases and a review of the literature.
Eichhorn JH; Young RH; Clement PB; Scully RE
Am J Surg Pathol; 2002 Oct; 26(10):1243-58. PubMed ID: 12360039
[TBL] [Abstract] [Full Text] [Related]
